2020 Shaffer Research Grants
For information about Shaffer Grants and research reports prior to 2013, please contact Glaucoma Research Foundation
Spacing: small
Spacing: small
![2020 Shaffer Research Grants 1 Steven Bassnett, Phd](https://glaucoma.org/wp-content/uploads/2024/02/0006_Steven-Bassnett.webp)
Steven Bassnett, PhD
Washington University School of Medicine
Funded by The Dr. Miriam Yelsky Memorial Research Grant
Project: Role of LOXL1 Propeptide Aggregation in Pseudoexfoliation Glaucoma
Summary: This study examined the composition of the insoluble material that accumulates in the eyes of patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
![2020 Shaffer Research Grants 2 Stewart Bloomfield, Phd](https://glaucoma.org/wp-content/uploads/2024/02/0005_Stewart-Bloomfield.webp)
Stewart Bloomfield, PhD
State University of New York College of Optometry
Funded by The Frank Stein and Paul S. May Grants for Innovative Glaucoma Research
Project: Retinal Gap Junctions Form Novel Targets for Neuroprotective Therapy in Glaucoma
Summary: The use of IOP-lowering drugs, the current mainstay treatment for glaucoma, is often insufficient to prevent progressive visual loss in patients.
![2020 Shaffer Research Grants 3 Alex Huang, Md, Phd](https://glaucoma.org/wp-content/uploads/2024/02/0004_Alex-Huang.webp)
Alex Huang, MD, PhD
Doheny Eye Institute
Funded by Dr. James and Elizabeth Wise
Project: Investigating Subconjuctival Lymphatics for the Treatment of Glaucoma and Eye Disorders
Summary: The subconjunctival space of the eye is often used in the treatment of eye diseases.
![2020 Shaffer Research Grants 4 Tatjana Jakobs, Md](https://glaucoma.org/wp-content/uploads/2024/02/0002_Tatjana-Jakobs.webp)
Tatjana Jakobs, MD
Schepens Eye Research Institute
Funded by The Frank Stein and Paul S. May Grants for Innovative Glaucoma Research
Project: The Transcription Factor Runx1 as a Novel Mediator of Astrocyte Reactivity in the Optic Nerve
Summary: We have identified several candidate molecules and we have shown neuroprotective activity for at least one of them.
![2020 Shaffer Research Grants 5 Rachel Kuchtey, Md, Phd](https://glaucoma.org/wp-content/uploads/2024/02/0000_Kuchtey.webp)
Rachel Kuchtey, MD, PhD
Vanderbilt Eye Institute
Project: Investigation of Ocular Biomechanical Defects in Mice with Microfibril and Elastic Fiber Defects
Summary: Glaucoma is defined as a type of optic nerve damage which cannot be reversed at the present time.
![2020 Shaffer Research Grants 6 Herbert Lachman, Md](https://glaucoma.org/wp-content/uploads/2024/02/0001_Herbert-Lachman-.webp)
Herbert Lachman, MD
Albert Einstein College of Medicine
Funded by The Edward Joseph Daly Foundation
Project: Gene Expression Profiling in Trabecular Meshwork Cells derived from Induced Pluripotent Stem Cells made from Patients with Lowe Syndrome, a Genetic Disorder that causes Cataracts and Glaucoma
Summary: Glaucoma is one of the most common causes of blindness.
![2020 Shaffer Research Grants 7 Matthew B. Veldman, Phd](https://glaucoma.org/wp-content/uploads/2024/02/0008_Matthew-Weldman.webp)
Matthew B. Veldman, PhD
Medical College of Wisconsin
Funded by a special gift from Akorn, Inc. and their employees
Project: Zebrafish Retinal Ganglion Cell Survival in the Context of Pro-Apoptotic Bax Signaling
Summary: Loss of vision in patients with glaucoma is the result of disconnection between the eye and brain.
![2020 Shaffer Research Grants 8 Trent A. Watkins, Phd](https://glaucoma.org/wp-content/uploads/2024/02/0009_Trent-Watkins.webp)
Trent A. Watkins, PhD
Baylor College of Medicine
Project: Highly Parallel Assessment of RGC Regenerative and Neuroprotective Targets
Summary: A major impediment to the development of new treatments to preserve and/or restore vision in glaucoma is the large number of potential therapeutic targets to be evaluated.